UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Mine Safety
MSA
$7.49B
| $661K | ﹤0.01% |
11,499
+600
| +6% | +$32.9K |
|
1702
TriMas Corp
TRS
$1.48B
| $660K | ﹤0.01% |
21,710
+1,129
| +5% | +$31.4K |
|
1703
Unifirst Corp
UNF
$5.21B
| $657K | ﹤0.01% |
6,200
| – | – |
|
|
MBFI
1704
DELISTED
MB Financial Corp
MBFI
| $657K | ﹤0.01% |
24,298
| – | – |
|
|
PNK
1705
DELISTED
Pinnacle Entertainment Inc.
PNK
| $657K | ﹤0.01% |
26,098
| – | – |
|
1706
Ironwood Pharmaceuticals
IRWD
$698M
| $656K | ﹤0.01% |
51,100
+2,747
| +6% | +$29.9K |
|
1707
Neogen
NEOG
$2.46B
| $656K | ﹤0.01% |
43,195
+2,400
| +6% | +$35.7K |
|
|
RWT
1708
Redwood Trust
RWT
$569M
| $656K | ﹤0.01% |
33,697
+1,500
| +5% | +$30K |
|
|
AAV
1709
DELISTED
Advantage Oil & Gas Ltd
AAV
| $656K | ﹤0.01% |
97,400
| – | – |
|
|
MEAS
1710
DELISTED
MEASUREMENT SPECIALTIES INC
MEAS
| $655K | ﹤0.01% |
7,607
+507
| +7% | +$35.1K |
|
1711
Power Integrations
POWI
$3.42B
| $654K | ﹤0.01% |
22,742
| – | – |
|
1712
Take-Two Interactive
TTWO
$43.8B
| $654K | ﹤0.01% |
29,397
+400
| +1% | +$8.19K |
|
1713
Monro
MNRO
$402M
| $653K | ﹤0.01% |
12,268
+600
| +5% | +$32.9K |
|
1714
United Bankshares
UBSI
$6.68B
| $653K | ﹤0.01% |
20,199
+1,100
| +6% | +$33.5K |
|
1715
Healthcare Services Group
HCSG
$1.54B
| $651K | ﹤0.01% |
22,098
| – | – |
|
1716
Franklin Electric
FELE
$4.84B
| $649K | ﹤0.01% |
16,099
| – | – |
|
1717
Stratasys
SSYS
$769M
| $648K | ﹤0.01% |
5,700
-99,272
| -95% | -$9.73M |
|
1718
Bloomin' Brands
BLMN
$919M
| $646K | ﹤0.01% |
28,786
| – | – |
|
|
GTY
1719
Getty Realty Corp
GTY
$2.06B
| $646K | ﹤0.01% |
34,270
+1,114
| +3% | +$21.1K |
|
1720
Mueller Industries
MLI
$15.5B
| $644K | ﹤0.01% |
87,592
+4,400
| +5% | +$32K |
|
1721
Enpro
NPO
$7.08B
| $644K | ﹤0.01% |
8,799
+500
| +6% | +$36K |
|
|
CYBX
1722
DELISTED
CYBERONICS INC
CYBX
| $643K | ﹤0.01% |
10,299
+600
| +6% | +$36.5K |
|
|
CYS
1723
DELISTED
CYS Investments Inc.
CYS
| $642K | ﹤0.01% |
71,195
| – | – |
|
1724
Genesco
GCO
$433M
| $641K | ﹤0.01% |
7,799
| – | – |
|
1725
Silicon Laboratories
SLAB
$7.23B
| $640K | ﹤0.01% |
12,999
-5,002
| -28% | -$238K |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.